Source AP ©

Heart risks front and center as diabetes drug faces scrutiny in US

U.S. government health advisers are being asked Monday to consider whether heart risks associated with the widely used diabetes drug Avandia outweigh its benefits in helping some or all patients.

Information from dozens of studies of the GlaxoSmithKline PLC drug points to an increased risk of heart attack, Food and Drug Administration reviewers said. The regulatory agency is seeking advice from a joint panel of outside experts on whether the drug should be pulled from the market or restricted to use in select patients and branded with prominent warnings. It isn't required to follow the advice of its advisory committees but usually does.

The FDA moved up the date of Monday's meeting following the May publication of a study by The New England Journal of Medicine that generated new concerns about Avandia's safety. The pooled analysis of 42 studies revealed a 43 percent higher risk of heart attack for those taking Avandia compared with people taking other diabetes drugs or no diabetes medication.

Glaxo, meanwhile, says its own data show no increase in heart risks with Avandia compared with other diabetes drugs.

About 1 million Americans with Type 2 diabetes use Avandia to control blood sugar by increasing the body's sensitivity to insulin. That sort of treatment has long been presumed to lessen the heart risks already associated with the disease, which is linked to obesity. News that Avandia, also called rosiglitazone, might actually increase those risks would represent a "serious limitation" of the drug's benefit, according to the FDA.

More than 5.8 million people voted for Nicholas Maduro at the presidential election in Venezuela. This is more than a quarter of registered voters. Why did those people vote for the man, who, as Western media write, took Venezuela to the brink of collapse?

Venezuela may expect another Panama scenario from 1989
Comments
Ukraine's exit from Commonwealth of Independent States will affect common Ukrainians most
USA sanctions Russian oligarchs and heads of state-run companies
USA sanctions Russian oligarchs and heads of state-run companies
USA sanctions Russian oligarchs and heads of state-run companies
Ukraine's exit from Commonwealth of Independent States will affect common Ukrainians most
Russian air defences ready to shoot down NATO drones and reconnaissance aircraft over Crimea
Ukraine's exit from Commonwealth of Independent States will affect common Ukrainians most
Russian air defences ready to shoot down NATO drones and reconnaissance aircraft over Crimea
Russian air defences ready to shoot down NATO drones and reconnaissance aircraft over Crimea
Russian air defences ready to shoot down NATO drones and reconnaissance aircraft over Crimea
British football fans spineless to unleash World War Three in Russia during World Cup
Russian air defences ready to shoot down NATO drones and reconnaissance aircraft over Crimea
British football fans spineless to unleash World War Three in Russia during World Cup
Beautiful and terrifying: Russia shows video of Bulava ICBM underwater salvo launch
Kremlin on failed nuclear missile tests: 'Listen to President Putin and believe him!'
Kremlin wants foreign invaders out of Syria
Kremlin on failed nuclear missile tests: 'Listen to President Putin and believe him!'
What may happen to foreign tourists traveling for 2018 World Cup in Russia
Kremlin on failed nuclear missile tests: 'Listen to President Putin and believe him!'
Russian special services detain Hizb ut-Tahrir members in Crimea
Russian special services detain Hizb ut-Tahrir members in Crimea